Dapagliflozin attenuates AKI to CKD transition in diabetes by activating SIRT3/PGC1-α signaling and alleviating aberrant metabolic reprogramming

Huimin Li(Yichang Central People's Hospital), Zhixia Song(ShenZhen People’s Hospital), Hua Huang(Sun Yat-sen University), Yao Xia(China Three Gorges University), Lang Shi(China Three Gorges University), Yafei Zhang(Yichang Central People's Hospital), Ruchi Yue(China Three Gorges University), Bin Hu(XinHua Hospital), Hongchu Zha(China Three Gorges University), Jiefu Zhu(China Three Gorges University), Jia‐Yi Wang(China Medical University)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
July 26, 2024
Cited by 13


Related Papers